Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.105
Sell
RSI(14)
28.127
Sell
STOCH(KDJ)(9,3,3)
8.541
Oversold
ATR(14)
0.273
High Vlolatility
CCI(14)
-126.104
Sell
Williams %R
95.276
Oversold
TRIX(12,20)
-2.522
Sell
StochRSI(14)
37.332
Neutral
Search
Co-Diagnostics Inc
CODXAdd to Watchlist
1.440USD
-0.120-7.69%
Close 07-31 16:00（ET）Quotes delayed by 15 min
5.19MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-7.69%
5 Days
-31.43%
1 Month
-53.55%
6 Months
-38.98%
Year to Date
+754.09%
1 Year
+456.84%
Key Figures
1.600Open
1.641High
374.26KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
10.39%Turnover Ratio
1.560Prev. Close
1.410Low
435.52KTurnover
LossP/E Static
0.32P/B
0.00%Div Yield TTM
-128.83%ROA
46.50052wk High
0.51Volume Ratio
-37.64MNet Profit
3.60MShares
-1054.6482EPS TTM
2.91Beta
-154.38%ROE
1.26052wk Low
14.81%Amplitude
-207.78%Gross Margin
5.19MMarket Cap
-3.65Reward/Risk
13.12%Risk Rate
TradingKey Stock Score of Co-Diagnostics Inc
Currency: USD Updated: 2026-07-31Key Insights
Co-Diagnostics Inc's fundamentals are relatively very healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 109 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 30.00.In the medium term, the stock price is expected to remain stable.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Co-Diagnostics Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Co-Diagnostics Inc Highlights
StrengthsRisks
Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.
Growing
The company is in a growing phase, with the latest annual income totaling USD 622.49K.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 622.49K.
Overvalued
The company’s latest PE is -0.00, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 248.15K shares, decreasing 39.01% quarter-over-quarter.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.83.
Analyst Rating
Based on
2
analysts
Hold
Current Rating
30.000
Target Price
+1171.19%
Upside Space
Co-Diagnostics Inc News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
2
analysts
Hold
Current Rating
30.000
Target Price
+1171.19%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
88
Total
4
Median
7
Average
Company name
Ratings
Analysts
Co-Diagnostics Inc
CODX
2
Intuitive Surgical Inc
ISRG
35
Boston Scientific Corp
BSX
34
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
29
Veeva Systems Inc
VEEV
29
1
2
3
...
18
Indicators
Moving Average
Indicators
Value
Direction
MA5
1.592
Sell
MA10
1.935
Sell
MA20
2.265
Sell
MA50
3.750
Sell
MA100
2.793
Sell
MA200
1.771
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Co-Diagnostics Inc Info
Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.
Ticker SymbolCODX
CompanyCo-Diagnostics Inc
CEOEgan (Dwight H)
Websitehttps://codiagnostics.com/
Shareholders
Related Instruments
-1.69%
-0.46%
+0.12%
-0.57%
-0.75%
+0.13%
-6.42%
-0.35%
+1.72%
-0.17%
-2.98%
+1.54%
-0.29%
-0.98%
+0.13%
+0.06%
-0.84%
-0.24%
-0.69%
-0.78%Popular Instruments
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.640
-24.790 (-7.43%)
200.760
+5.720 (+2.93%)
4041.430
-61.400 (-1.50%)
FAQs
What is the current price of Co-Diagnostics Inc (CODX)?
The current price of Co-Diagnostics Inc (CODX) is 1.44.
What is the symbol of Co-Diagnostics Inc?
The ticker symbol of Co-Diagnostics Inc is CODX.
What is the 52-week high of Co-Diagnostics Inc?
The 52-week high of Co-Diagnostics Inc is 46.50.
What is the 52-week low of Co-Diagnostics Inc?
The 52-week low of Co-Diagnostics Inc is 1.26.
What is the market capitalization of Co-Diagnostics Inc?
The market capitalization of Co-Diagnostics Inc is 5.19M.
Is Co-Diagnostics Inc (CODX) currently rated as Buy, Hold, or Sell?
According to analysts, Co-Diagnostics Inc (CODX) has an overall rating of signal_hold, with a price target of 30.00.
What is the Earnings Per Share (EPS TTM) of Co-Diagnostics Inc (CODX)?
The Earnings Per Share (EPS TTM) of Co-Diagnostics Inc (CODX) is -1057.64.